Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for the treatment of cannabis dependence: working mechanisms
2024-519855-27-00Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cannabis use disorder (CUD) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Primary endpoint at Day 14 after study start. Started Jan 2025; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on 2024-519855-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519855-27-00.